IL17A and atopic eczema: Decreases IL-17 secretion while increasing Treg differentiation, thus controlling skin inflammation in a model of DTH [180].Reduces Th2 and Th17 cell proliferation, increases Treg, attenuating atopic dermatitis-related immune responses [181].